关注
Jordan Bryan
标题
引用次数
引用次数
年份
Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
RM Meyers, JG Bryan, JM McFarland, BA Weir, AE Sizemore, H Xu, ...
Nature genetics 49 (12), 1779-1784, 2017
16382017
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
SM Corsello, RT Nagari, RD Spangler, J Rossen, M Kocak, JG Bryan, ...
Nature cancer 1 (2), 235-248, 2020
6082020
Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
JM McFarland, ZV Ho, G Kugener, JM Dempster, PG Montgomery, ...
Nature communications 9 (1), 4610, 2018
3472018
An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence
E Dhimolea, R de Matos Simoes, D Kansara, A Al’Khafaji, J Bouyssou, ...
Cancer cell 39 (2), 240-256. e11, 2021
1892021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cells
M Sheffer, E Lowry, N Beelen, M Borah, SNA Amara, CC Mader, JA Roth, ...
Nature Genetics 53 (8), 1196-1206, 2021
682021
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias
R de Matos Simoes, R Shirasaki, SL Downey-Kopyscinski, GM Matthews, ...
Nature cancer 4 (5), 754-773, 2023
172023
Interactive or static reports to guide clinical interpretation of cancer genomics
SW Gray, J Gagan, E Cerami, AM Cronin, H Uno, N Oliver, C Lowenstein, ...
Journal of the American Medical Informatics Association 25 (5), 458-464, 2018
162018
Weighted classification cascades for optimizing discovery significance in the higgsml challenge
L Mackey, J Bryan, MY Mo
NIPS 2014 Workshop on High-energy Physics and Machine Learning, 129-134, 2015
72015
Routine Estimation of Dissolved Organic Matter Sources Using Fluorescence Data and Linear Least Squares
J Bryan, P Hoff, CL Osburn
ACS ES&T Water 3 (8), 2073-2082, 2023
42023
Likelihood ratio statistics for gene set enrichment in Alzheimer's disease pathways
J Bryan, A Mandan, G Kamat, WK Gottschalk, A Badea, KJ Adams, ...
Alzheimer's & Dementia 17 (4), 561-573, 2021
42021
Systematic characterization of genes representing preferential molecular vulnerabilities for myeloma cells compared to other neoplasias-implications for the biology and …
RDM Simoes, R Shirasaki, SL Downey-Kopyscinski, G Matthews, H Yiguo, ...
Blood 134, 4407, 2019
42019
Smaller p-values in genomics studies using distilled auxiliary information
JG Bryan, PD Hoff
Biostatistics 24 (1), 193-208, 2023
3*2023
Linear Source Apportionment using Generalized Least Squares
JG Bryan, PD Hoff, CL Osburn
Technometrics, 1-16, 2024
12024
Comments on contemporary uses of machine learning for electronic health records
J Bryan, D Li
North Carolina Medical Journal 85 (4), 2024
12024
Opportunities and challenges for analyzing cancer data at the inter-and intra-institutional levels
J Wu, J Bryan, SM Rubinstein, L Wang, M Lenoue-Newton, R Zuhour, ...
JCO Precision Oncology 4, 743-756, 2020
12020
A compromise criterion for weighted least squares estimates
J Bryan, H Zhou, D Li
arXiv preprint arXiv:2404.00753, 2024
2024
Advanced Topics in Introductory Statistics
J Bryan
Duke University, 2023
2023
Large scale viability screening with PRISM underscores non-inhibitory properties of small molecules
L de Waal, K Larpenteur, L Wang, C Zhu, J Bryan, M Kocak, C Aghia, ...
Cancer Research 82 (12_Supplement), 1883-1883, 2022
2022
The multirank likelihood for semiparametric canonical correlation analysis
JG Bryan, J Niles-Weed, PD Hoff
arXiv preprint arXiv:2112.07465, 2021
2021
Large scale phenotypic screening using PRISM, integrated with functional genomic screening and transcriptional profiling accelerates target identification of cytotoxic small …
K Larpenteur, L de Waal, L Wang, M Kocak, J Bryan, S Bender, S Barkho, ...
MOLECULAR CANCER THERAPEUTICS 18 (12), 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20